{
    "nctId": "NCT03762044",
    "briefTitle": "New Therapeutic Approach in Upper Limb Lymphedema Secondary to Breast Cancer: Activity-oriented Proprioceptive Antiedema Therapy (TAPA)",
    "officialTitle": "New Therapeutic Approach in Upper Limb Lymphedema Secondary to Breast Cancer: Activity-oriented Proprioceptive Antiedema Therapy (TAPA). A Randomized Controlled Therapy",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer Lymphedema, Post-Mastectomy Secondary Lymphedema",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 51,
    "primaryOutcomeMeasure": "Volume",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Upper limb lymphedema secondary to breast cancer grade I and II, according to the Working Group of the XI International Lymphology Congress\n\nExclusion Criteria:\n\n* Upper limb lymphedema secondary to breast cancer grade 0 and III, according to the Working Group of the XI International Lymphology Congress",
    "sex": "FEMALE",
    "minimumAge": "14 Years",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}